Table 1:
Crude incidence and baseline characteristic of MS patients in 2013–2014
| Variables | n (%) | 2013 Population | CI | n (%) | 2014 Population | CI |
|---|---|---|---|---|---|---|
| Sex | 749 | 485 | ||||
| Female (916) | 565 (75.4) | 6167000 | 9.16 | 351 (72.4) | 6228000 | 5.63 |
| Male (318) | 184 (24.6) | 6266000 | 2.93 | 134 (27.6) | 6331000 | 2.11 |
| Age group | ||||||
| ≤19 | 64 (8.5) | 3279000 | 1.95 | 36 (7.4) | 3286000 | 1.09 |
| 20–24 | 153 (20.4) | 1107000 | 13.82 | 89 (18.4) | 1030000 | 8.64 |
| 25–29 | 184 (24.6) | 1463000 | 12.57 | 131(27.0) | 1414000 | 9.26 |
| 30–34 | 148 (19.8) | 1374000 | 10.77 | 94 (19.3) | 1440000 | 6.52 |
| 35–39 | 97 (13.0) | 1050000 | 9.23 | 65 (13.4) | 1107000 | 5.87 |
| 40–44 | 60 (8.0) | 908000 | 6.60 | 29 (6.0) | 917000 | 3.16 |
| 45≥ | 43 (5.7) | 3252000 | 1.32 | 41 (8.5) | 3365000 | 1.21 |
CI: Crude Incidence per 100000 population